Cumulus Oncology raises $5.6 million funding led by Eos Advisory
Cumulus Oncology, said to be Europe’s first oncology biotech creation company, has secured a £4.1 million ($5.6 million) investment led by St Andrews-based investment firm Eos Advisory. Scottish Enterprise invested alongside Eos as Cumulus plans further scale, while an additional £1.5 million ($2 million) will follow in the coming months Cumulus was founded in 2017 for the identification […]
